8257 — Genes Tech group Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$230.00m
- HK$326.41m
- TWD931.96m
- 38
- 68
- 89
- 76
Annual cashflow statement for Genes Tech group Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 197 | 118 | -82.4 | 126 | 92.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 17.3 | 56.6 | 269 | 14.1 | 27.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -188 | 36.5 | -146 | -194 | -67.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 63.6 | 254 | 82.5 | -11.2 | 94.6 |
| Capital Expenditures | -37.5 | -5.29 | -18.1 | -12 | -3.33 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.135 | 0.1 | 0.438 | 1.06 | 1.15 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -37.4 | -5.19 | -17.6 | -10.9 | -2.19 |
| Financing Cash Flow Items | -13.6 | -12.2 | -13.8 | -18.7 | -18.1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -63.8 | -171 | -11.4 | -66.6 | -55 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -41.1 | 76.7 | 66.7 | -88.9 | 43.6 |